Acute Coronary Syndromes

Acute coronary syndrome (ACS) is most commonly caused by a heart attack (myocardial infarction) where blood flow to the heart is suddenly blocked. This is usually caused by a blood clot from a ruptured coronary artery atherosclerotic plaque. Other causes include spontaneous coronary artery dissection (SCAD), which most commonly occurs in women. ACS is usually treated in a cath lab with angioplasty and the placement of a stent to prop the vessel open.

RSS icon
Thumbnail

Routine stress tests after PCI make little difference, even in high-risk ACS patients

Some care teams have turned to a more active follow-up strategy for high-risk PCI patients—but it may not provide much value. 

Thumbnail

A historic moment in diabetes care: Teva launches first-ever generic GLP-1 in US

Teva Pharmaceuticals has officially launched generic liraglutide injections in the United States. Novo Nordisk currently sells liraglutide under the brand name Victoza.

cannabis use disorder marijuana joint weed smoking

Risk of death from CVD skyrockets when women use cannabis

“While the use of cannabis continues to gain popularity, its broader effects on public health within the general population are not yet fully understood,” one researcher said.

womanconsultation.jpg

Mediterranean diet helps women live longer, reducing heart disease and cancer risks

Researchers explored decades of data from more than 25,000 women, sharing their findings in JAMA Network Open.

Newsweek ranked the 50 best heart hospitals in the world

3 in 5 US adults projected to have CVD by 2050, with a price tag of $1.8T—can cardiologists ‘turn the tide’?

More than 60% of adults in the United States are expected to have at least one form of cardiovascular disease by 2050, according to new data published by the American Heart Association. Fortunately, evidence does suggest that healthier lifestyles are starting to become more common as time goes on.

Cardiologist Valentin Fuster, MD, PhD, received the World Heart Federation’s 2024 Lifetime Achievement Award Saturday, May 25, during the ninth annual World Heart Summit in Geneva, Switzerland.

World Heart Federation honors cardiologist Valentin Fuster for lifetime of service

“I am proud of this award, particularly because it represents Mount Sinai’s worldwide scientific contributions and dedication to advancements in the cardiovascular field,” Fuster said.

The U.S. Food and Drug Administration (FDA) announced that Vyaire Medical has recalled the twin tube samples lines from its Vyntus CPX Metabolic Cart due to ongoing safety concerns. This is a Class I recall, which means the FDA believes using these devices “may cause serious injuries or death.”

FDA announces new Class I recall of CPET devices due to choking hazard

If left unchecked, the devices could put patients at risk of serious injuries or death as they undergo cardiopulmonary evaluations. 

HeartFlow Plaque Analysis

AI-powered coronary plaque assessments show ‘strong agreement’ with IVUS

HeartFlow's noninvasive Plaque Analysis technology, which uses AI to evaluate CCTA images, delivered assessments that mostly lined up with IVUS results. 

Displaying 41 - 48 of 665

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.